Skip to main content
×
×
Home

Single oral doses of 13C forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: potential problems in interpretation of folate bioavailability studies

  • A. J. A. Wright (a1), P. M. Finglas (a1), J. R. Dainty (a1), D. J. Hart (a1), C. A. Wolfe (a1), S. Southon (a1) and J. F. Gregory (a2)...
Abstract

Single 13C6-labelled doses of pteroylmonoglutamic acid (PteGlu; 634 nmol) or 5-formyltetrahydrofolic acid (431–569 nmol) were given to fasted adult volunteers, and the rise in total and 13C-labelled plasma 5-methyltetrahydrofolic acid metabolite monitored over 8 h by HPLC and liquid chromatography–MS. The dose-adjusted area under the curve (AUC) for total (labelled plus unlabelled) plasma 5-methyltetrahydrofolic acid following a 5-formyltetrahydrofolic acid test dose was 155 % that obtained following a PteGlu test dose. Surprisingly, an average 60 and 40 % of the total plasma 5-methyltetrahydrofolic acid response to [13C6]PteGlu and [13C6]5-formyltetrahydrofolic acid, respectively, was unlabelled; an observation never before reported. Short-term kinetics of plasma [13C6]5-methyltetrahydrofolic acid showed a slower initial rate of increase in plasma concentration and longer time to peak following an oral dose of [13C6]PteGlu compared with that for an oral dose of [13C6]5-formyltetrahydrofolic acid, while the [13C6]5-methyltetrahydrofolic acid AUC for [13C6]5-formyltetrahydrofolic acid was 221 % that for [13C6]PteGlu. These data indicate that PteGlu and 5-formyltetrahydrofolic acid, which are thought to be well absorbed (about 90 %) at physiological doses, exhibit dramatically different rates and patterns of plasma response. A limitation in the rate of reduction of PteGlu before methylation could result in slower mucosal transfer of [13C6]5-methyltetrahydrofolic acid derived from [13C6]PteGlu into the plasma. This, when coupled with an observed similar plasma clearance rate for [13C6]5-methyltetrahydrofolic acid metabolite derived from either folate test dose, would yield a comparatively smaller AUC. These findings suggest potential problems in interpretation of absorption studies using unlabelled or labelled folates where the rate of increase, the maximum increase, or the AUC, of plasma folate is employed for test foods (mainly reduced folates) v. a ‘reference dose’ of PteGlu.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Single oral doses of 13C forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: potential problems in interpretation of folate bioavailability studies
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Single oral doses of 13C forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: potential problems in interpretation of folate bioavailability studies
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Single oral doses of 13C forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: potential problems in interpretation of folate bioavailability studies
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: P. M. Finglas, fax +44 1603 507723, email paul.finglas@bbsrc.ac.uk
References
Hide All
Anonymous (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338, 131137.
Bailey, LB, Barton, LE, Hillier, SE & Cerda, JJ (1988) Bioavailability of mono and polyglutamyl folate in human subjects. Nutr Rep Int 38, 509518.
Bhandari, SD & Gregory, JF (1992) Folic acid 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats. J Nutr 122, 18471854.
Blakley, RL (1969) The biochemistry of folic acid and related pteridines. In Frontiers of Biology, pp. 9294. [Neuberger, A and Tatum, EL, editors]. London: North–Holland.
Blount, BC, Mack, MM & Wehr, CM (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94, 32903295.
Bousey, CJ, Beresford, SA, Omenn, GS & Motulsky, AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease – probable benefits of increasing folic acid intakes. JAMA 274, 10491057.
Bower, C, Stanley, FJ, Croft, M, De Clerk, NH, Davis, RE & Nicol, DJ (1993) Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects. Br J Nutr 69, 827834.
Brown, JP, Scott, JM, Foster, FG & Weir, DG (1973) Ingestion and absorption of naturally occurring pteroylmonoglutamates (folates) in man. Gastroenterology 64, 223232.
Clifford, AJ, Arjomand, A, Dueker, SR, Schneider, PD, Buchholz, BA & Vogel, JS (1998) The dynamics of folic acid metabolism in an adult given a small tracer dose of 14C-folic acid. Adv Exp Med Biol 445, 239251.
Czeizel, AE & Dudas, I (1992) Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. N Engl J Med 327, 3235.
Fenech, M, Noakes, N, Clifton, P & Topping, D (1999) Aleurone flour is a rich source of bioavailable folate in humans. J Nutr 129, 11141119.
Finglas, PM, Dainty, JR, Hart, D, Wolfe, C, Wright, AJ, Wright, D, Southon, S & Gregory, JF (2002 a) Modelling of labelled absorbed folates using plasma in humans. FASEB J 16, A748
Finglas, PM, Witthöft, CM, Vahteristo, L et al. (2002) Use of an oral/intravenous dual-label stable-isotope protocol to determine folic acid bioavailability from fortified cereal grain foods in women. J Nutr 132, 936939.
Gregory, JF (1990) Improved synthesis of [3′, 5′-2H2] folic acid: extent and specificity of deuterium labelling. J Agric Food Chem 38, 10731076.
Gregory, JF (1997) Bioavailability of folate. Eur J Clin Nutr 51, Suppl. 1, S54S59.
Gregory, JF (2001) Case study: Folate bioavailability. J Nutr 131, Suppl. 4, 1376S1382S.
Gregory, JF, Bhandari, SD, Bailey, LB, Toth, JP, Baumgartner, TG & Cerda, JJ (1992) Relative bioavailability of deuterium-labeled monoglutamyl tetrahydrofolates and folic acid in human subjects. Am J Clin Nutr 55, 11471153.
Hart, DJ, Finglas, PM, Wolfe, CA, Mellon, F, Wright, AJA & Southon, S (2002) Determination of 5-methyltetrahydrofolate (13C-labelled and unlabelled) in human plasma and urine by combined liquid chromatography mass spectrometry (LC/MS). Anal Biochem 305, 206213.
Kelly, P, McPartlin, J, Goggins, M, Weir, DG & Scott, JM (1997) Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 65, 17901795.
Lucock, MD, Wild, J, Smithells, RW & Hartley, R (1989) In vivo characterization of the absorption and biotransformation of pteroylmonoglutamic acid in man: a model for future studies. Biochem Med Metab Biol 42, 3042.
Markkanen, T (1968) Absorption tests with natural folate material in controls and in gastrectomized patients. Am J Clin Nutr 21, 473481.
Mathews, CK & Huennekens, FM (1963) Further studies on dihydrofolate reductase. J Biol Chem 238, 34363442.
Maunder, P, Finglas, PM, Mallet, AI, Mellon, FA, Razzaque, MA, Ridge, B, Vahteristo, L & Witthöft, C (1999) The synthesis of folic acid, multiply labelled with stable isotopes, for bioavailability studies in human nutrition. J Chem Soc Perkin Trans 1, 13111323.
Moran, RG, Keyomasri, K & Colman, PD (1986) Preparation of (6S)-5-formyltetrahydrofolate labelled at high specific activity with 14C- and 2H-. Meth Enzymol 122, 309313.
Nephew, KP & Huang, TH-M (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 190, 125133.
Perry, J (1971) Folate analogues in normal mixed diets. Br J Nutr 21, 435441.
Perry, J & Chanarin, I (1970) Intestinal absorption of reduced folate compounds in man. Br J Haematol 18, 329339.
Perry, J & Chanarin, I (1972) Observations on folate absorption with particular reference to folate polyglutamate and possible inhibitors to its absorption. Gut 13, 544550.
Pietrzik, K, Hages, M & Remer, T (1990) Methodological aspects in vitamin bioavailability testing. J Micronutr Anal 7, 207222.
Prinz-Langenohl, R, Bronstrup, A, Thorand, B, Hages, M & Pietrzik, K (1999) Availability of food folate in humans. J Nutr 129, 913916.
Rogers, LM, Pfeiffer, CM, Bailey, LB & Gregory, JF (1997) A dual-label stable-isotopic protocol is suitable for determination of folate bioavailability: Evaluation of urinary excretion and plasma folate kinetics of intravenous and oral doses of [13C5] and [2H2]folic acid. J Nutr 127, 23212327.
Scott, JM & Weir, DG (1976) Folate composition, synthesis and function in natural materials. Clinics in Haematology 5, 547568.
Seager, H, Aulton, ME & Morton, FSS (1988) Drug delivery systems; soft gelatin capsules. In: Pharmaceutics. The Science of Dosage Form Design, pp. 330340. [Aulton, ME, editor]. London: Churchill Livingstone.
Selhub, J, Dhar, GJ & Rosenberg, IH (1983) Gastrointestinal absorption of folates and antifolates. Pharmacol Ther 20, 397418.
Shane, B (1995) Folate chemistry and metabolism. In Folate in Health and Disease, pp. 122 [Bailey, LB, editor]. New York, NY: Marcel Dekker.
Steinberg, SE, Campbell, CL & Hillman, RS (1979) Kinetics of the normal folate enterohepatic cycle. J Clin Invest 64, 8388.
Van den Berg, H, Finglas, PM & Bates, C (1994) FLAIR Intercomparisons on serum and red cell folate. Int J Vitam Nutr Res 64, 288293.
Wolfe, CA, Finglas, PM, Hart, D, Wright, AJA & Southon, S (2001) Isotopic methods to detect food folates. Innovat Food Sci Emerg Technol 1, 297302.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed